InnovAge made a big splash with its IPO in March 2021. A year and a half later, its enrollment was capped in two different states because of resource shortages, and its stock price had fallen by 85%. Now it’s trying to make a comeback.
Click here to view original post
News
Zynex, Inc. Sets Second Quarter 2023 Earnings Call
ENGLEWOOD, Colo., July 20, 2023 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold […]
News
Study Finds Link Between Brain Injury And Criminal Behavior
A new study led by researchers at the University of Colorado Anschutz Medical Campus, Brigham and Women’s Hospital and Harvard Medical School has found that damage to a specific region of the brain may contribute […]
News
How Do Cell ‘Safety Caps’ Influence Aging, Inflammation and Cancer?
Out of the approximately 30 trillion cells that make up your human body, about 330 billion die and are replaced every single day. That’s a whole lot of cell turnover throughout the course of a […]
